Circulating vaccine-derived poliovirus type 1 confirmed in Papua New Guinea

Outbreak response to be launched to stop further spread of the virus

A child is protected from lifelong polio paralysis through OPV vaccination. © WHO
A child is protected from lifelong polio paralysis through OPV vaccination. © WHO

Following identification last month of an acute flaccid paralysis (AFP) case from which vaccine-derived poliovirus type 1 (VDPV1) had been isolated, genetic sequencing of two VDPV1s from two non-household contacts of the AFP case has now confirmed that VDPV1 is circulating and is being officially classified as a  ‘circulating’ VDPV type 1 (cVDPV1).

The National Department of Health (NDOH) of Papua New Guinea is closely working with the GPEI partners in launching a comprehensive response. Some of the immediate steps include conducting large-scale immunization campaigns and strengthening surveillance systems that help detect the virus early. These activities are also being strengthened in neighboring provinces.

The GPEI and its partners are continuing to work with regional and country counterparts and partners in supporting the Government of Papua New Guinea and local public health authorities in conducting a full field investigation, risk assessment and to support the planning, implementation and monitoring of the outbreak response.

For more information:

Contact Oliver Rosenbauer, Communications Officer, Global Polio Eradication Initiative, tel: +41 79 500 6536

Related resources


Related News

   19/10/2021
For a few incredible eradicators, a life’s purpose doesn’t stop at retirement
   13/10/2021
Virus isolated from Rivne province in north-west of country
   10/10/2021
The recommendation further advances nOPV2 as a critical new tool in the fight against circulating vaccine-derived poliovirus type 2 (cVDPV2)
   29/09/2021
More often than not, the road to a meaningful triumph is a bumpy one.
   27/08/2021
Learn how the type 2 novel oral polio vaccine (nOPV2) is being rolled out across Africa to help more sustainably address outbreaks of a non-wild form of polio, cVDPV2, and protect children across the continent.
   19/08/2021
19 August 2021